| Literature DB >> 24649003 |
Tsuyoshi Morimoto1, Kota Hirai1, Akiko Fukumura1, Hiromitsu Takakura1, Takashi Koike1, Takashi Shimizu1.
Abstract
L-asparaginase (L-asp) is a well-known anticancer agent used in the treatment of acute lymphoblastic leukemia (ALL) in children. However, it is also known to induce several acute complications, such as acute pancreatitis. This is a presentation of two pediatric acute lymphoblastic leukemia (ALL) cases of asparaginase-associated pancreatitis (AAP) diagnosed at an early stage based on elevated serum elastase-1 levels, in the presence of normal serum amylase levels. Early diagnosis and treatment of AAP, although imperative, is occasionally difficult if only standard diagnostic procedures are followed. Elastase-1 is a potentially useful marker for the early diagnosis of AAP. Therefore, the measurement of elastase-1 levels, in addition to amylase and lipase levels, is recommended in L-asp-treated patients.Entities:
Keywords: acute lymphoblastic leukemia; asparaginase; chemotherapy; elastase-1; pancreatitis
Year: 2013 PMID: 24649003 PMCID: PMC3917048 DOI: 10.3892/br.2013.108
Source DB: PubMed Journal: Biomed Rep ISSN: 2049-9434